NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that it received its latest U.S. Food and Drug Administration 510 clearance for the Pulse® platform, after receiving CE certification earlier this summer.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://www.biospace.com/article/releases/nuvasive-receives-latest-fda-510-k-clearance-for-pulse-platform-and-announces-commercial-launch/?s=93